Global Neonatal Ventilation and Nasal CPAP Market- Impact of COVID-19 Analysis
The impact of COVID-19 on the global neonatal ventilation and nasal CPAP market has affected in a positive way. Scarcity of ventilators during this pandemic has been an important issue throughout the world. The governments of various countries have sanctioned loans for boosting the production and manufacturing of ventilators in health care sectors. Thus, there has been significant changes in healthcare infrastructure, as small cities and towns are incorporating modern facilities to encompass ventilator systems within their hospitals and nursing homes. All these factors are key drivers to boost application of intensive care ventilators in COVID-19 pandemic.
Global Neonatal Ventilation and Nasal CPAP Market- Drivers
Neonatal ventilation and nasal CPAP are effective treatment methods for respiratory distress in neonates. There has been sustainable growth in research and development in the global neonatal ventilation and nasal CPAP market from last decade. For instance, in 2016, B&B Medical Technologies announced that the Bubbler 12.5 cm H2O Pressure Relief Manifold is available for immediate sale. The unit is for use in bubble CPAP systems and is a companion product to B&B’s popular Bubbler Water Seal CPAP Valve. The Pressure Relief Manifold is U.S. Food and Drug Administration (FDA) approved and carries the CE mark.
According to data published by US National Library of Medicine in 2014, around 1% of infants develop respiratory distress syndrome globally and in the U.S., 12% of babies were born prematurely having risk of respiratory distress and accounted for 2.3% of infant deaths due to respiratory distress syndrome in 2013. Such factors are expected to drive the global neonatal ventilation and nasal CPAP market growth over the forecast period.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients